Understanding FeNO
Because the test is simple, non invasive and suitable for adults and children, it has become an important part of asthma diagnosis and ongoing management across primary and secondary care.
This page explains what FeNO is, how it works and what different FeNO levels mean so that patients and clinicians can better understand the role of FeNO in modern asthma pathways.

FeNO Explained
A raised FeNO level can indicate eosinophilic airway inflammation, which often responds well to inhaled corticosteroid treatment. This makes FeNO especially useful in supporting asthma diagnosis and guiding early treatment decisions.
Because the test is quick, easy to perform and does not require specialist equipment outside of the device itself, it is ideal for use in GP surgeries, respiratory hubs and specialist clinics.

What FeNO Levels Mean
Low FeNO
A low FeNO level suggests there is little or no eosinophilic inflammation present. Asthma linked to this type of inflammation is less likely or may be well controlled with current treatment.
Intermediate FeNO
An intermediate level should be interpreted alongside symptoms, history and inhaler technique. Inflammation may be present but not strongly active.
High FeNO
A high FeNO level indicates significant airway inflammation. This supports a diagnosis of asthma and suggests the patient is likely to benefit from inhaled corticosteroids. High FeNO levels can also identify patients whose asthma is not well controlled or who may not be taking their medication as prescribed.
Understanding FeNO levels helps clinicians make clearer decisions regarding diagnosis, treatment and follow up.
FeNO for Asthma Diagnosis
Raised FeNO results support a diagnosis of asthma, particularly when used alongside history taking and lung function tests. FeNO is helpful when spirometry is normal or when symptoms are unclear. It allows clinicians to understand whether inflammation is contributing to symptoms and whether inhaled corticosteroids are likely to be effective.
Using FeNO early in the diagnostic process can reduce delays, prevent unnecessary treatments and improve confidence in clinical decisions.
FeNO for Asthma Monitoring
FeNO monitoring can
• identify poor asthma control early
• support decisions about adjusting inhaled corticosteroid doses
• highlight issues with medication adherence
• track how inflammation responds to treatment
• reduce unnecessary escalations in therapy
Regular FeNO measurements give a clearer picture of airway inflammation than symptoms alone and support more personalised asthma management.
FeNO for Children
In children, FeNO can
• help confirm whether inflammation is present
• support early diagnosis when symptoms are unclear
• guide inhaled corticosteroid treatment
• reduce the risk of over or under treating asthma
• assist clinicians in reviewing asthma control during follow up
Because childhood asthma can be difficult to assess through symptoms alone, FeNO provides a clear and objective measure that supports safe and effective treatment.



